Mascoma Wealth Management LLC lessened its position in shares of Humana Inc. (NYSE:HUM – Free Report) by 24.2% during the second quarter, HoldingsChannel reports. The institutional investor owned 326 shares of the insurance provider’s stock after selling 104 shares during the quarter. Mascoma Wealth Management LLC’s holdings in Humana were worth $122,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors also recently added to or reduced their stakes in HUM. Intech Investment Management LLC grew its position in shares of Humana by 46.2% during the fourth quarter. Intech Investment Management LLC now owns 42,287 shares of the insurance provider’s stock worth $19,359,000 after acquiring an additional 13,356 shares during the last quarter. AdvisorShares Investments LLC acquired a new position in Humana in the fourth quarter valued at $421,000. Sei Investments Co. increased its stake in Humana by 0.4% in the first quarter. Sei Investments Co. now owns 61,897 shares of the insurance provider’s stock valued at $21,462,000 after purchasing an additional 264 shares during the period. Cetera Advisors LLC raised its holdings in shares of Humana by 472.1% in the first quarter. Cetera Advisors LLC now owns 10,098 shares of the insurance provider’s stock valued at $3,501,000 after buying an additional 8,333 shares during the last quarter. Finally, Cetera Investment Advisers boosted its stake in shares of Humana by 249.0% during the first quarter. Cetera Investment Advisers now owns 20,945 shares of the insurance provider’s stock worth $7,262,000 after buying an additional 14,944 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.
Wall Street Analysts Forecast Growth
Several analysts have commented on the company. TD Cowen upped their price objective on Humana from $396.00 to $407.00 and gave the company a “buy” rating in a research note on Wednesday, July 24th. Morgan Stanley began coverage on Humana in a research note on Monday, June 24th. They set an “equal weight” rating and a $374.00 price target for the company. Cantor Fitzgerald reiterated a “neutral” rating and issued a $395.00 price objective on shares of Humana in a research report on Monday, August 19th. Truist Financial upped their price objective on shares of Humana from $355.00 to $400.00 and gave the stock a “hold” rating in a research report on Monday, July 15th. Finally, Piper Sandler began coverage on shares of Humana in a report on Wednesday, June 26th. They issued an “overweight” rating and a $392.00 target price on the stock. Thirteen research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, Humana presently has a consensus rating of “Hold” and an average price target of $396.35.
Humana Price Performance
Humana stock opened at $363.53 on Wednesday. The firm has a market capitalization of $43.81 billion, a PE ratio of 22.64, a P/E/G ratio of 3.16 and a beta of 0.51. Humana Inc. has a 52 week low of $298.61 and a 52 week high of $530.54. The firm’s 50-day simple moving average is $367.75 and its 200 day simple moving average is $347.03. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.70.
Humana (NYSE:HUM – Get Free Report) last announced its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.89 by $1.07. The company had revenue of $29.54 billion for the quarter, compared to the consensus estimate of $28.52 billion. Humana had a net margin of 1.53% and a return on equity of 16.12%. The company’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $8.94 earnings per share. On average, equities research analysts predict that Humana Inc. will post 16.14 EPS for the current fiscal year.
Humana Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Monday, September 30th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 0.97%. The ex-dividend date of this dividend is Monday, September 30th. Humana’s dividend payout ratio (DPR) is presently 22.04%.
Humana Company Profile
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Further Reading
- Five stocks we like better than Humana
- High Dividend REITs: Are They an Ideal Way to Diversify?
- These 2 Sectors Could Provide Roadmap for the Market
- Business Services Stocks Investing
- 3 Stocks to Own if You Are Bearish on The Market
- Bank Stocks – Best Bank Stocks to Invest In
- Is Wingstop The Perfect Fast Casual Restaurant Model?
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.